However, in absence of ANXA2 in MSC or in presence of the plasmin activation inhibitor ε-aminocaproic acid (EACA) no increase of B-ALL cell numbers was observed (Fig. 6A). Here, ANXA2 is linked to precursor B-cell acute lymphoblastic leukemia.